Tamoxifen for primary breast cancer prevention in BRCA heterozygotes.
Robson
M
M
Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000235:genetics / Q000517:prevention & control*; D005260:Female; D019398:Genes, BRCA1; D006579:Heterozygote; D006801:Humans; D009154:Mutation / Q000235:genetics; D011960:Receptors, Estrogen; D013629:Tamoxifen / Q000627:therapeutic use*
D018931:Antineoplastic Agents, Hormonal; D011960:Receptors, Estrogen; D013629:Tamoxifen